Abstract:Objective: To analyze the screening, diagnosis, epidemiology, pregnancy outcomes and treatment status in hepatitis C virus antibody-positive pregnant women, in order to provide clinical evidence for further improving prevention and control of maternal and infant safety. Methods: Data of 246 HCV antibody-positive pregnant women admitted to the Second Hospital of Nanjing from January 2014 to December 2019 were analyzed by epidemiological survey research method. Statistical analysis was performed according to different data using t-test, χ2 test, corrected χ2 test or Fisher's exact test. Results: 80 of 246 HCV antibody-positive women had confirmed infection before pregnancy. Of these, 85% were HCV RNA positive, and 16 became pregnant after antiviral therapy. Prenatal examination during pregnancy found that 166 cases were HCV RNA positive, and the HCV RNA positive rate was 81.93%. In the relationship between infection route and birth cohort in HCV antibody-positive pregnant women, there was a statistically significant differences in the proportions of transmission route among birth cohort (χ2=115.6, P＜0.001). With the delay of birth cohort, the proportion of infection through drug use was decreased (P＜0.001), while the proportion of acupuncture-associated infection (P=0.043) and infant hospitalization history were increased (P=0.005). Among pregnancy complications, HCV antibody-positive pregnant women in HCV RNA＜5.0 E+02 IU/ml and ≥5.0 E+02 IU/ml groups had intrahepatic cholestasis of pregnancy (χ2=4.73, P=0.030) and gestational hypertension (χ2=8.65, P=0.003), and the difference in incidence was statistically significant. Postpartum treatment strategy data analysis showed that the treatment rate was highest in the first year of postpartum, and then showed an upward trend year by year, with a statistically significant difference (χ2=17.26,P =0.004). Conclusion: Anti-HCV screening rates are lower among pregnant and reproductive age women. HCV screening should be used as an important supplementary means to strengthen maternal safety and health education management during pregnancy. Active postpartum antiviral therapy, with particularly emphasis on management within the first year after delivery, can significantly improve the treatment rate among women of child bearing age.

The Inspecting and Analysis of Women Before Pregnancy or in the Early Period of Pregnancy in KunMing

Prevalence of serum antibodies to TORCH among women before pregnancy or in the early period of pregnancy in Beijing.

Investigation of TORCH infection among women before pregnancy or in the early period of pregnancy in Beijing

Study of the Measure of TORCH-IgM in Pregnant Women and the Relationship with Outcomes of Abnormal Fetus

Analysis on TORCH Screening Results among Women at Childbearing Age in Beijing

Analysis on syphilis infection among 6366 pregnant women and their infants in Zhoushan archipelago

Laboratory measures after TORCH serological IgM positive before and during pregnancy

Serological Screening of TORCH Pathogen Infections in Infertile Women of Childbearing Age in Northwest China

Analysis on the infection status of TORCH in 19 500 infertile women and 4 141 pregnant women

Expert consensus on standardized TORCH laboratory detection and clinical application

Seroepidemiology of TORCH Antibodies in the Reproductive-Aged Women in China.

Risk Factors and Control Countermeasures of Puerperal Hospital Infection

The effect of syphilis treatment during pregnancy on serological test results in infants born to syphilis mothers

Re-evaluation on Perinatal Screening of TORCH

Analysis of detection result of four prenatal infection markers of pregnant women

Seasonal influence on TORCH infection and analysis of multi‐positive samples with indirect immunofluorescence assay

[A Survey of the Current Status of Research on the Diagnosis and Treatment of Hepatitis C Virus Antibody-Positive Pregnant Women].

Relationship Between Poor Pregnancy Outcome and TORCH Infection in Pregnant Women

The Screening of Rubella Virus, Cytomegalovirus, Hepatitis B Virus, and Toxoplasma gondii Antibodies in Prepregnancy and Reproductive-Age Women in Tabriz, Iran

su qian di qu xin sheng er ji ying er torch gan ran de jian ce fen xi

Experimental Study of Toxoplasma Infection among Pregnant Women in Jilin Area